Clinical evidence on the efficacy and safety of an antioxidant optimized 1.5% salicylic acid (SA) cream in the treatment of facial acne: an open, baseline‐controlled clinical study. Issue 2 (19th January 2013)
- Record Type:
- Journal Article
- Title:
- Clinical evidence on the efficacy and safety of an antioxidant optimized 1.5% salicylic acid (SA) cream in the treatment of facial acne: an open, baseline‐controlled clinical study. Issue 2 (19th January 2013)
- Main Title:
- Clinical evidence on the efficacy and safety of an antioxidant optimized 1.5% salicylic acid (SA) cream in the treatment of facial acne: an open, baseline‐controlled clinical study
- Authors:
- Zheng, Yue
Wan, Miaojian
Chen, Haiyan
Ye, Congxiu
Zhao, Yue
Yi, Jinling
Xia, Yue
Lai, Wei - Abstract:
- <abstract abstract-type="main" xml:lang="en" id="srt12022-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="srt12022-sec-0001" sec-type="section"> <title>Background/purpose</title> <p>Acne pathogenesis is multifactorial and includes inflammation. Combining active ingredients targeting multiple components of acne pathogenesis may yield optimal outcomes. This study investigates the safety and efficacy of an antioxidant optimized topical salicylic acid (SA) 1.5% cream containing natural skin penetration enhancers in combination with antioxidant activity for treatment of facial acne.</p> </sec> <sec id="srt12022-sec-0002" sec-type="section"> <title>Methods</title> <p>A total of 20 patients with facial acne, aged 19–32 years (2 males, 18 females; mean age 26.1 ± 3.2), were enrolled. Patients were treated with topical 1.5% SA cream and instructed to apply the cream as a thin film over the affected area twice daily (in the morning and evening) for 4 weeks. Inflammatory severity, numbers of papules and pustules were evaluated by investigators at day 0 and weekly, and patients ranked their improvement.</p> </sec> <sec id="srt12022-sec-0003" sec-type="section"> <title>Results</title> <p>In all, 95% of patients improved: 20% had complete clearing, 30% had significantly improved, 15% had moderate improvement, 30% had mild improved, and there was no response in 5% of the patients by 4 weeks of treatment. No side effects were observed.</p> </sec> <sec<abstract abstract-type="main" xml:lang="en" id="srt12022-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="srt12022-sec-0001" sec-type="section"> <title>Background/purpose</title> <p>Acne pathogenesis is multifactorial and includes inflammation. Combining active ingredients targeting multiple components of acne pathogenesis may yield optimal outcomes. This study investigates the safety and efficacy of an antioxidant optimized topical salicylic acid (SA) 1.5% cream containing natural skin penetration enhancers in combination with antioxidant activity for treatment of facial acne.</p> </sec> <sec id="srt12022-sec-0002" sec-type="section"> <title>Methods</title> <p>A total of 20 patients with facial acne, aged 19–32 years (2 males, 18 females; mean age 26.1 ± 3.2), were enrolled. Patients were treated with topical 1.5% SA cream and instructed to apply the cream as a thin film over the affected area twice daily (in the morning and evening) for 4 weeks. Inflammatory severity, numbers of papules and pustules were evaluated by investigators at day 0 and weekly, and patients ranked their improvement.</p> </sec> <sec id="srt12022-sec-0003" sec-type="section"> <title>Results</title> <p>In all, 95% of patients improved: 20% had complete clearing, 30% had significantly improved, 15% had moderate improvement, 30% had mild improved, and there was no response in 5% of the patients by 4 weeks of treatment. No side effects were observed.</p> </sec> <sec id="srt12022-sec-0004" sec-type="section"> <title>Conclusion</title> <p>This study demonstrates the efficacy and safety of this optimized topical 1.5% SA cream containing natural skin penetration enhancers in combination with antioxidant activity when applied twice daily for the reduction of facial acne; in particular, it is most effective for mild‐to‐moderate acne.</p> </sec> </abstract> … (more)
- Is Part Of:
- Skin research and technology. Volume 19:Issue 2(2013)
- Journal:
- Skin research and technology
- Issue:
- Volume 19:Issue 2(2013)
- Issue Display:
- Volume 19, Issue 2 (2013)
- Year:
- 2013
- Volume:
- 19
- Issue:
- 2
- Issue Sort Value:
- 2013-0019-0002-0000
- Page Start:
- 125
- Page End:
- 130
- Publication Date:
- 2013-01-19
- Subjects:
- Skin -- Research -- Periodicals
Skin -- Diseases -- Periodicals
Skin -- Physiology -- Periodicals
616.5 - Journal URLs:
- http://www.blackwellpublishing.com/journal.asp?ref=0909-752X&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-0846 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/srt.12022 ↗
- Languages:
- English
- ISSNs:
- 0909-752X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8295.948000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4083.xml